New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
19:03 EDTTKMR, MONTekmira receives $1.5M milestone payment from Monsanto
Tekmira Pharmaceuticals (TKMR) announced that it has received a $1.5M milestone payment from Monsanto (MON) following completion of specified program developments. The development milestone is part of the research program under the option agreement Tekmira signed with the agriculture company, which was announced on January 13. The option agreement relates to Tekmira's proprietary delivery technology and intellectual property for use in agricultural applications. The potential value of the transaction could reach up to $86.2M, following the successful completion of all program milestones.
News For TKMR;MON From The Last 14 Days
Check below for free stories on TKMR;MON the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
07:14 EDTMONMonsanto Intacta-traited soy seed largely sold out, says Piper Jaffray
Subscribe for More Information
September 11, 2014
12:03 EDTMONUSDA raises U.S. corn yield forecast to record
In its monthly World Agricultural Supply and Demand Estimates, or WASDE, report, the U.S. Department of Agriculture's corn yield forecast is raised 4.3 bushels per acre to a record 171.7 bushels. Corn production for 2014/15 is forecast 363 million bushels higher at a record 14,395 million bushels. Total 2014/15 corn usage is projected at 13,605 million bushels, up 170 million from last month. Although a record, usage is expected up just 5 million bushels from 2013/14 as export prospects remain constrained by large foreign carryin stocks, the USDA wrote. Publicly traded companies in the agriculture space include Agrium (AGU), Andersons (ANDE), Archer Daniels (ADM), Bunge (BG), CF Industries (CF), Compass Minerals (CMP), DuPont (DD), Intrepid Potash (IPI), Monsanto (MON), Mosaic (MOS), Potash (POT) and Syngenta (SYT).
10:20 EDTTKMRNebraska Medical Center not naming Ebola drug, The Street reports
Nebraska Medical Center is not releasing the name of the experimental Ebola drug being given to Dr. Rick Sacra, The Street's Adam Feuerstein reports, citing an emailed response from the hospital. Traders are speculating Tekmira (TKMR) is the manufacturer of the drug, Feuerstein points out. Sarepta (SRPT) disclosed that it is not involved in the treatment of Sacra, added Feuerstein. Shares of Tekmira are up 3% to $19.65 in morning trading. Reference Link
September 10, 2014
11:29 EDTMONMonsanto's Intacta remains on track, says Credit Suisse
Credit Suisse said Monsanto Intacta demand remains strong and check's indicate it is fully on track to meet the high end of its 10m-12M acre guidance for Brasil.
11:20 EDTMONMonsanto: Intacta demand 'in line,' pre-pays above expectation, Bloomberg says
Subscribe for More Information
10:43 EDTMONMonsanto shares defended at JPMorgan
Subscribe for More Information
09:39 EDTMONMonsanto view downgraded to Negative from Mixed at OTR Global
Subscribe for More Information
September 7, 2014
13:57 EDTTKMRGlaxoSmithKline Ebola vaccine works in tests on monkeys, Bloomberg says
Subscribe for More Information
September 5, 2014
14:42 EDTMONCHS Inc. names David Black as Chief Information Officer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use